Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable
Open Access
- 7 April 2022
- journal article
- Published by IOS Press in Tumor Biology
- Vol. 44 (1), 37-52
- https://doi.org/10.3233/tub-211571
Abstract
BACKGROUND: A large number of infiltrating CD3- and CD8-positive inflammatory cells indicates an improved survival in colorectal cancer (CRC), similar to many other cancers. OBJECTIVE: We investigated the prognostic value of different combinations of CD3- and CD8-positive immune cells in CRC patients. METHODS: The densities of CD3- and CD8-positive cells in intratumoral and stromal tissues were evaluated from 539 patients, for which we calculated a CD3 tumor–stroma index, a CD8 tumor–stroma index, and a CD3–CD8 tumor–stroma index. RESULTS: High CD3 and CD8 tumor–stroma indices associated with stage I to II disease (p < 0.001 for both). The CD3 tumor–stroma index associated with a colonic tumor location (p = 0.006), while the CD8 tumor–stroma index associated with right-sided tumors (p < 0.001) and histological grade 3 tumors (p = 0.032). High intratumoral and stromal densities for CD3- and CD8-positive immune cells, the CD3 tumor–stroma index, the CD8 tumor–stroma index, and the CD3–CD8 tumor–stroma index all indicated a better DSS. CONCLUSIONS: The CD3 tumor–stroma index carries a strong prognostic value in CRC, and none of the CD3 and CD8 combinations we analyzed proved superior.Keywords
This publication has 32 references indexed in Scilit:
- The immune score as a new possible approach for the classification of cancerJournal of Translational Medicine, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Immune infiltration in human tumors: a prognostic factor that should not be ignoredOncogene, 2009
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal CancerJournal of Clinical Oncology, 2009
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid StructuresJournal of Clinical Oncology, 2008
- CD4 T cells: fates, functions, and faultsBlood, 2008
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cellsNature, 2006
- Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck CancersClinical Cancer Research, 2006
- American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon CancerJournal of Clinical Oncology, 2004